Publications

2017

Measuring Prices and Availability of Locally-produced and Imported Medicines

2016

Media Release: Insulin Discounts Lower Price Burden for Americans, but Insulin Still Not Affordable Worldwide

Medicines Policy in Moldova

Politica cu privire la medicamente în Republica Moldova

TACD Resolution on Medicinal Products and Medical Devices in the TTIP Agreement

Fact or Fiction? What Healthcare Professionals Need to Know about Pharmaceutical Marketing

Prices and Availability of Locally Produced and Imported Medicines in Ethiopia

Prices and Availability of Locally Produced and Imported Medicines in Tanzania

Health Systems Advocacy Partnership: Fact Sheet

Health Action International Response to Report by Lancet Commission on Essential Medicines

Press Release: Health Action International Receives €460,000 Grant from Dutch Ministry of Foreign Affairs to Fight Snakebite Death & Disability in Sub-Saharan Africa

Press Release: Health Action International Launches Educational Guide to Help EU Healthcare Students & Professionals Counter Ill Effects of Pharmaceutical Marketing

Joint Letter: Civil Society Urges US Secretary Burwell to Expand Access to Patented Cancer Drugs in Developing Countries

Press Release: Report Reveals Danger Of TTIP Locking Europe & Us Into Higher Drug Prices, Failed Pharma Innovation Model

Policy Report: TTIP and Affordable Medicines – How TTIP May Obstruct Progress Towards Sustainable Access To Medicines

Media Statement: HAI Response to Political Declaration of the United Nations High-level Meeting of the General Assembly on Antimicrobial Resistance

Media Statement: Health Action International Response to Report by UN High-level Panel on Access to Medicines

Open Letter to European Commision on June 2016 EU Council Conclusions

56 Non-profit Organisations Question US State Department Pressure Against Global Access to Medicines Initiatives – Letter to US Secretary of State, John Kerry

Recommendations for EU Governments to Improve Access & Innovation of Needed Medicines

Private Patents and Public Health: Changing intellectual property rules for access to medicines

Measures That Reduced Price of Patented HIV Medicines Should Be Used to Safeguard Access to New Essential Medicines

EU Trade Policy & Access to Medicines

EU Trade Policy & Access to Medicines

HAI Provides EU Member States with Recommendations that Promote Therapeutically Advantangeous and Affordable Medicines

Civil Society Urges Member States to Defend Need for Critical Review of IP System and Incentives for Medical Innovation

WHA69 Intervention on Global Medicine Shortages and the Safety and Accessibility of Children’s Medication

HAI and KEI Submit WHA69 Intervention on Follow-up CEWG Report

HAI Co-signs Letter to Obama Administration Regarding Alleged U.S. Interference in Colombian Health Measure

HAI Submits Intervention on Establishing a Global Development and Stewardship Framework for Antimicrobial Medicines and Other Interventions at WHA69